Optiver Holding B.V. Day One Biopharmaceuticals, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 1,012 shares of DAWN stock, worth $8,956. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,012Holding current value
$8,956% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
176Shares Held
70.3MCall Options Held
59.6KPut Options Held
23.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$56.9 Million10.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$54.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$40.1 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$32.9 Million0.56% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.72MShares$32.9 Million0.03% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $650M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...